Treatment Efficacy of the Transsylvian Approach Versus the Transtemporal Cortex Approach to Evacuate Basal Ganglia Hematoma Under a Microscope. Issue 2 (March 2016)

• Record Type: Journal Article
• Authors: Xu, Tao; Liu, Hao; Peng, Lin; Li, Hao; Wang, Jiying; Jiang, Yong; Gu, Yingjiang
• Is Part Of: Journal of craniofacial surgery. Volume 27:Issue 2(2016)
• Page Start: 308
• Page End: 312
• Publication Date: 2016-03
• Subjects: Basal ganglia hemorrhage -- lateral fissure -- meta-analysis -- microsurgery -- temporal cortex; Facial bones -- Surgery -- Periodicals; Skull -- Surgery -- Periodicals; Face -- Surgery -- Periodicals; Surgery, Plastic -- Periodicals; 617.52
• DOI: 10.1097/SCS.0000000000002323
• Languages: English
• ISSNs: 1049-2275

Abstract

Abstract : Abstract: This study aimed to evaluate the clinical efficacy of the transsylvian approach versus the transtemporal cortex approach to evacuate basal ganglia hemorrhage under a microscope. The relevant literature was collected from PubMed, Embase, Cochrane Central Register of Controlled Trials, Chinese Biomedical Literature database, and China National Knowledge Infrastructure databases. The meta-analysis was conducted by Stata 12.0 software. Seven studies were included in the meta-analysis. There were 659 patients, including 329 patients who were treated by the transsylvian approach and 330 patients who were treated by the transtemporal cortex approach. There were significant advantages in the transsylvian approach group, including a high clearance rate of hematoma (OR = 2.361; 95% CI: 1.443–3.861) and a better postoperative recovery (OR = 2.248; 95% CI: 1.598–3.160). A better postoperative recovery could also be found in patients with a history of hypertension (OR = 2.063; 95% CI: 1.429–2.980) and patients whose volume of hematoma ranged from 25 to 60 mL (OR = 2.275; 95% CI: 1.466–3.529). The authors conclude that there are significant advantages to the transsylvian approach, such as a high clearance rate of hematoma and a good postoperative recovery. These advantages should be taken into account when devising appropriate therapeutic strategies for patients with basal ganglia hematoma.